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Brooke^Spiegler syndrome (BSS, familial cylindroma-
tosis or turban tumor syndrome) is an inherited disease
characterized by neoplasms of the skin appendages
such as cylindroma, trichoepithelioma, and spiradenoma.
The disease has been mapped to 16q12-13, and muta-
tions in the CYLD gene have been identi¢ed in families
with this disorder. Of interest, multiple familial tri-
choepithelioma (MFT) has been described as a distinct
disorder characterized by the familial occurrence of tri-
choepitheliomas. MFT has been mapped to 9p21; how-
ever, to date a candidate gene has not been identi¢ed. In
this report, we describe a four-generation family with
BSS presenting predominantly with trichoepitheliomas
(resembling MFT phenotype). We identi¢ed a novel
missense mutation in the CYLD gene, designated
E474G, in the a¡ected individuals of this family. Our
¢ndings exemplify clinical heterogeneity within BSS
and extend the body of evidence that mutations in
CYLD are implicated in this disease. Although not con-
clusive, these ¢ndings suggest that BSS and MFT may
represent a single entity. Key words: familial cylindromato-
sis/turban tumor syndrome/cylindroma/trichoepithelioma/gen-
odermatosis. J Invest Dermatol 121:732 ^734, 2003
B
rooke^Spiegler syndrome (BSS), also known as fa-
milial cylindromatosis or turban tumor syndrome
(OMIM 132700, 605041) (Brooke, 1892; Spiegler,
1899), is an autosomal dominantly inherited disease
characterized by predisposition to neoplasms of the
skin appendages. The most commonly observed tumors are cy-
lindromas, trichoepitheliomas, and spiradenomas. Typically, these
tumors are located in the head and neck region, appear in early
adulthood, and gradually increase in size and number throughout
life. Cylindromas located on the scalp may eventually cover the
entire scalp, resulting in so called ‘‘turban tumors.’’ In addition to
tumors of the skin appendages, patients with BSS are also at risk
for developing tumors of the salivary glands. Basal cell mono-
morphic adenoma and adenocarcinoma of the parotid glands
have been described as a rare association in this disease (Antones-
cu and Terzakis, 1997; Jungehulsing et al, 1999). Although cylin-
dromas are usually benign tumors, malignant transformation to
cylindrocarcinomas is rare, but well documented (Gerretsen et
al, 1993). Cylindrocarcinoma or malignant cylindroma is a locally
aggressive tumor that often metastasizes, requiring careful moni-
toring of these patients (Gerretsen et al, 1995; Pizinger and Michal
2000; Durani et al, 2001).
The gene for familial cylindromas (thus for BSS) was mapped
to chromosome 16q12-13 by linkage analysis (Biggs et al, 1995).
Subsequently, the CYLD gene was discovered by positional clon-
ing, and mutations in CYLD were identi¢ed in families with this
disease (Bignell et al, 2000). In this report, we describe a large fa-
mily with BSS in which a novel missense mutation in CYLD has
been identi¢ed. Of interest, the a¡ected individuals of the family
described here exhibit a phenotype that resembles multiple famil-
ial trichoepithelioma (MFT).
MATERIALS ANDMETHODS
Genomic DNAwas extracted fromwhole blood using the PureGene DNA
isolation kit (Gentra Systems, Minneapolis, MN). The 17 coding exons of
the CYLD gene were ampli¢ed by PCR using speci¢c primers (the se-
quences of the primers are available upon request from the authors). For
mutation detection, the PCR products were sequenced using an automated
sequencing system (310, Applied Biosystems, Foster City, CA). The PCR
products were digested with MnlI at 371C for 12 h and analyzed on 1.5%
agarose/TBE minigels. The study has been approved by the institutional
IRB and patient blood samples were collected after signing the consent
forms.
RESULTS
Clinical data The family is of Turkish descent. The pedigree is
consistent with an autosomal dominant mode of inheritance
of the disease in this family (Fig 1). The a¡ected individuals
began developing skin tumors in the late teenage years. On
examination, all a¡ected persons had numerous papules pre-
dominantly on the nasolabial folds, nose, and upper lip
(Fig 2a). These papules were £esh colored, measuring 0.2 to
0.4 cm, and the histologic examination showed ¢ndings of
trichoepithelioma. Whereas most of the a¡ected persons were
noted to have skin lesions on the nasolabial folds, one family
member (II-3) had numerous papules on his entire back, of
which the histology was trichoepithelioma as well. None of
the a¡ected persons showed classic turban tumors and lacked
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skin lesions on the scalp. Nevertheless, upon careful skin
examination, one individual was noted to have isolated papules
on the scalp. The biopsies obtained from the scalp lesions
showed histologic ¢ndings of cylindroma.
Mutation detection DNA from 13 a¡ected and 3 una¡ected
family members were tested for mutations in the CYLD gene. A
transition of an adenine to a guanine at nucleotide 2240 in exon 16
was identi¢ed (Fig 2b). The mutation results in replacement of
glutamic acid (GAG) by glycine (GGG) at amino acid 747. The
mutation, designated as E747G, cosegregates with the disease in
the family (Fig 1). The mutation E747G abolishes a restriction
endonuclease site for the enzyme MnlI, which was used to
con¢rm the mutation (Fig 2d). The sequence alteration found in
this family was not observed in 200 unrelated, una¡ected controls.
DISCUSSION
The CYLD gene consists of 20 exons, of which the ¢rst three are
untranslated. When one copy of the gene is inactivated in the
germline, a¡ected individuals are predisposed to developing neo-
plasms of the skin appendages. Moreover, loss of heterozygosity
at the CYLD locus has been found in these tumors, suggesting
that CYLD functions as a tumor suppressor (Bignell et al, 2000).
To date, there have been two reports describing mutations in
families with BSS. Bignell et al (2000) reported mutations in
CYLD in 21 of 25 families with BSS. Recently, Gutierrez et al
(2002) described a family with a mutation in CYLD. All muta-
tions were located in the 30 two-thirds of the CYLD-coding se-
quence (exons 9^20), a region that is well conserved among its
orthologs. The mutation E747G described here is also within this
region. E747G missense mutation is predicted to be pathogenic in
this family owing to perfect cosegregation of the mutation with-
in the family and its absence in the control group, as well as con-
servation of this region of the protein among its orthologs
(Fig 2c). It is possible, but unlikely, that E747G represents a rare
polymorphismwithin CYLD. Nevertheless, we have not encoun-
tered this sequence variation in 200 healthy control patients. Of
interest, we have not noted any polymorphisms within exon 16
of CYLD.
A major and unique feature of BSS is the presence of hetero-
geneity of tumors in the a¡ected families.Whereas some families
present with cylindromas and trichoepitheliomas (Burrows et al,
1992), other families presenting with spiradenomas and trichoe-
pitheliomas (Weyers et al, 1993) have been described. Of interest,
MFT (OMIM 601606) described as a distinct syndrome is inher-
ited in an autosomal dominant pattern and is characterized by
multiple trichoepitheliomas. MFT has been mapped to 9p21
(Harada et al, 1996); however, to date a candidate gene has not
been identi¢ed in this region. Moreover, loss of heterozygosity
in sporadic trichoepitheliomas was demonstrated at 9q22.3
(48%), but not at 9p21 (Matt et al, 2000). In a di¡erent study, loss
of heterozygosity at 16q around the CYLD locus was shown in
one of two sporadic trichoepitheliomas studied (Leonard et al,
2001). Inter- and intrafamilial phenotypic variability has been
well documented in BSS. Gerretsen et al (1995) suggested that
both BSS and MFT may be caused by the same genetic defect,
Figure1. Clinical data and genetic analysis of the family with BSS.
(a) Biopsy-proven multiple trichoepitheliomas on the nose, nasolabial
folds, and the upper lip. (b) DNA sequence of exon 16 of CYLD from con-
trol and a¡ected individuals. (c) The alignment of human CYLD protein
(amino acids 741^752) and its orthologs. The conservation of glutamic acid
(E) at codon 747 is indicated. (d) The ¢gure shows MnlI digestion of the
PCR samples, which cleaves the wild-type allele in 249- and 113-bp frag-
ments. The mutation E747G abolishes the MnlI site, and therefore the
mutant allele does not cleave and shows the intact 362-bp PCR product.
Figure 2. Pedigree of the family. For individuals whose DNA samples
have been analyzed, the allele sequences at codon 747 have been indicated
as E (glutamic acid) or G (glycine). The una¡ected persons encode for an E
on both alleles (E/E), whereas the a¡ected persons are heterozygous for the
mutation and encode a G on the mutant allele (E/G).
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because both cylindroma and trichoepithelioma can occur in
the same patient or in di¡erent patients within a single family.
Recently, a four-generation family exhibiting phenotypic varia-
bility with a single germline mutation in CYLD was described
(Gutierrez et al, 2002). In this family, some a¡ected members had
cylindromas, whereas others had trichoepitheliomas as the predo-
minating tumor type. Of interest, the a¡ected individuals of the
family described here exhibit a phenotype that resembles MFT.
All of the a¡ected individuals of this family presented with mul-
tiple trichoeptiheliomas, with the exception of only one indivi-
dual who had cylindromas on the scalp. While not conclusive,
our ¢ndings and currently known data suggest that BSS and
MFTmay represent phenotypic variability of a single entity. Eva-
luation of families with MFTphenotype for mutations in CYLD
will help to clarify this issue.
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